Work

Natural Deep Eutectic Solvent-Based Enhancement of Naproxen Solubility for Oral Drug Delivery

Year: 2026
Type: article
Abstract: Naproxen is a widely used non-steroidal anti-inflammatory drug (NSAID) classified as BCS Class II, which means it has low aqueous solubility and high permeability. Because dissolution often limits how quickly such a drug reaches the bloodstream, poor solubility can hold back the performance of an oral dosage form. Deep eutectic solvents (DESs), and the subgroup called natural deep eutectic solvents (NADES), are tunable liquid media. Their hydrogen-bonding behaviour and polarity can be adjusted by changing the components and their ratios. This review asks whether NADES merit study as solubilising media for naproxen. It keeps apart what is established for DESs in general and what is still unknown for one particular L-proline–glucose mixture. Earlier work has measured naproxen solubility in choline-based and betaine-based DES–water mixtures. These results suggest that DES-assisted solubilization is feasible, but they cannot predict how a different composition will behave. The proposed 5:3 L-proline: glucose molar ratio is therefore a hypothesis that needs experimental confirmation. A reasonable study would move from solvent characterization to equilibrium solubility measured with proper controls, then to dilution and precipitation tests and compatibility checks, and only afterwards to a solid oral dosage form. Viscosity, water content, dose uniformity, stability and safety are the main practical concerns. Greater solubility in a solvent does not, by itself, mean faster dissolution from a finished product or better bioavailability. The review includes tables covering solvent properties, controls, risks and stage gates to support planning.
Language: English
Field: Chemistry
Open Access status: green
OpenAlex ID: W7235569087
FWCI:
Cites:
Cited by:
Related to: 10